QALY – Reward Health

Clinical Practice Guidelines and Protocols

Trump/Musk killed AHRQ, but in a sense, the death has been playing out over 25 years. Recalling 4 eras of the agency and my dream for its eventual rebirth.

Slashing and Dissolving As reported by the Kaiser Family Foundation’s Health News site blog, last week the Trump administration “dissolved” the Agency for Healthcare Research

Dr. Ward April 8, 2025 No Comments

ACO Reimbursement and Gain Sharing

CMS Innovation Center engages in linguistic manipulation and health economics denialism in new definition of “VBC”

There are many good people at the CMS Innovation Center (CMMI). They mean well. They are our friends. But friends need to call out friends

Dr. Ward January 30, 2024 4 Comments

Cost-Effectiveness Analysis (CEA)

Conceptualizing “over-treatment” waste: Don’t deny health economics

A Health Policy Brief published in Health Affairs on December 13, 2012 referenced an analysis published last April in JAMA regarding waste in health care.

Dr. Ward December 23, 2012 No Comments

Cost-Effectiveness Analysis (CEA)

The debate about what to maximize when selecting candidates for care management programs: Accuracy? ROI? Net Savings? Or Cost-Effectiveness?

When doing analysis, it is really important to clarify up front what it is you are actually trying to figure out. This sounds so obvious.

Dr. Ward September 17, 2011 No Comments

ACO Culture

Reports of the death of Cost-Effectiveness Analysis in the U.S. may have been exaggerated: The ongoing case of Mammography

Guidelines for the use of mammograms to screen for breast cancer have been the topic of one of the fiercest and longest-running debates in medicine.

Dr. Ward August 13, 2011 No Comments